Sunset, LA (PRWEB) July 21, 2014
Sleep disturbances such as insomnia, hypersomnia, and poor sleep quality are closely correlated with depression. According to a study published by the National Institutes of Health: "About three quarters of depressed patients have insomnia symptoms, and hypersomnia is present in about 40% of young depressed adults and 10% of older patients, with a preponderance in females. The symptoms cause huge distress, have a major impact on quality of life, and are a strong risk factor for suicide." http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181883/.
Antidepressants and sleep aids are commonly used to manage these problems and come with undesirable side effects, such as dependency risk, memory/blackout issues, weight gain, sexual side effects, daytime drowsiness, etc. In fact, some antidepressants have even shown to worsen sleep quality. In addition, sleep issues during pregnancy are common, and safe sleep aid options for this population are extremely limited-pregnancy category B or C.
Both sleep quality and mood regulation are governed by neurotransmitter production. Over 50% of the general population possess the genetic polymorphism, MTHFR (methylenehydrofolatereductase), a defect in the enzyme crucial to synthesizing the critical b vitamins essential in producing neurotransmitters.
Findings published in The American Journal of Epidemiology entitled, "Methylenetetrahydrofolate Reductase (MTHFR) Genetic Polymorphi
Copyright©2014 Vocus, Inc.
All rights reserved